Allergic diseases and the effect of inhaled epinephrine in children with acute bronchiolitis: Follow-up from the randomised, controlled, double-blind, Bronchiolitis ALL trial

The Lancet Respiratory Medicine

Volumn 3, Issue 9, 2015, Pages 702-708

  Skjerven, Håvard Ove ^a,b   Rolfsjord, Leif Bjarte ^a,c   Berents, Teresa Løvold ^a,b   Engen, Hanne ^d   Dizdarevic, Edin ^e   Midgaard, Cathrine ^f   Kvenshagen, Bente ^g   Aas, Marianne Hanneborg ^h   Hunderi, Jon Olav Gjengstø ^a,b,g   Stensby Bains, Karen Eline ^a,b   Mowinckel, Petter ^b   Carlsen, Kai Håkon ^a,b   Lødrup Carlsen, Karin C ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c INNLANDET HOSPITAL TRUST   (Norway)

^d TELEMARK HOSPITAL   (Norway)

^e Center for Cancer Treatment   (Norway)

^f VESTFOLD HOSPITAL TRUST   (Norway)

^g Østfold Hospital Trust   (Norway)

^h Vestre Viken Hospital   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BRONCHODILATING AGENT;

ALLERGIC DISEASE; ALLERGIC SENSITISATION; ARTICLE; ATOPIC DERMATITIS; BRONCHIOLITIS; BRONCHUS OBSTRUCTION; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; INFANT; INTENTION TO TREAT ANALYSIS; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEBULIZATION; PRESCHOOL CHILD; PRICK TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; TREATMENT RESPONSE; AIRWAY OBSTRUCTION; CLINICAL TRIAL; COMPLICATION; DERMATITIS, ATOPIC; DOUBLE BLIND PROCEDURE; HYPERSENSITIVITY; INHALATIONAL DRUG ADMINISTRATION; NEWBORN; NORWAY; SKIN TEST; TIME FACTOR;

ADMINISTRATION, INHALATION; AIRWAY OBSTRUCTION; BRONCHIOLITIS; BRONCHODILATOR AGENTS; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; DOUBLE-BLIND METHOD; EPINEPHRINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERSENSITIVITY; INFANT; INFANT, NEWBORN; LENGTH OF STAY; MALE; NORWAY; SKIN TESTS; TIME FACTORS;

EID: 84941178892     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(15)00319-7     Document Type: Article

References (27)

1. Stockman LJ, Curns AT, Anderson LJ, Fischer-Langley G Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997-2006. Pediatr Infect Dis J 2012, 31:5-9.
2. Leader S, Kohlhase K Respiratory syncytial virus-coded pediatric hospitalizations, 1997 to 1999. Pediatr Infect Dis J 2002, 21:629-632.
3. Court SD The definition of acute respiratory illnesses in children. Postgrad Med J 1973, 49:771-776.
4. Skjerven HO, Hunderi JO, Brugmann-Pieper SK, et al. Racemic adrenaline and inhalation strategies in acute bronchiolitis. N Engl J Med 2013, 368:2286-2293.
5. Ralston SL, Lieberthal AS, Meissner HC, et al. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics 2014, 134:e1474-e1502.
6. Mittal V, Darnell C, Walsh B, et al. Inpatient bronchiolitis guideline implementation and resource utilization. Pediatrics 2014, 133:e730-e737.
7. Parikh K, Hall M, Teach SJ Bronchiolitis management before and after the AAP guidelines. Pediatrics 2014, 133:e1-e7.
8. Mecklin M, Hesselmar B, Qvist E, Wennergren G, Korppi M Diagnosis and treatment of bronchiolitis in Finnish and Swedish children's hospitals. Acta Paediatr 2014, 103:946-950.
9. Asher MI, Montefort S, Bjorksten B, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006, 368:733-743.
10. Devulapalli CS, Carlsen KC, Haland G, et al. Severity of obstructive airways disease by age 2 years predicts asthma at 10 years of age. Thorax 2008, 63:8-13.
11. Hanifin JM Diagnostic features of atopic dermatitis. Acta Derm Venereol 1980, 92(suppl):44-47.
12. Wang R, Lagakos SW, Ware JH, Hunter DJ, Drazen JM Statistics in medicine-reporting of subgroup analyses in clinical trials. N Engl J Med 2007, 357:2189-2194.
13. Sormani MP, Bruzzi P Reporting of subgroup analyses from clinical trials. Lancet Neurol 2012, 11:747.
14. Baumer JH SIGN guideline on bronchiolitis in infants. Arch Dis Child Educ Pract Ed 2007, 92:ep149-ep151.
15. Zorc JJ, Hall CB Bronchiolitis: recent evidence on diagnosis and management. Pediatrics 2010, 125:342-349.
16. Schroeder AR, Mansbach JM Recent evidence on the management of bronchiolitis. Curr Opin Pediatr 2014, 26:328-333.
17. Gadomski AM, Brower M Bronchodilators for bronchiolitis. Cochrane Database Syst Rev 2010, 12. CD001266.
18. Hartling L, Bialy LM, Vandermeer B, et al. Epinephrine for bronchiolitis. Cochrane Database Syst Rev 2011, 6. CD003123.
19. Saglani S, Payne DN, Zhu J, et al. Early detection of airway wall remodeling and eosinophilic inflammation in preschool wheezers. Am J Respir Crit Care Med 2007, 176:858-864.
20. Holt PG, Sly PD Viral infections and atopy in asthma pathogenesis: new rationales for asthma prevention and treatment. Nat Med 2012, 18:726-735.
21. Berankova K, Uhlik J, Honkova L, Pohunek P Structural changes in the bronchial mucosa of young children at risk of developing asthma. Pediatr Allergy Immunol 2014, 25:136-142.
22. Pickles RJ, DeVincenzo JP Respiratory syncytial virus (RSV) and its propensity for causing bronchiolitis. J Pathol 2015, 235:266-276.
23. Blanken MO, Rovers MM, Molenaar JM, et al. Respiratory syncytial virus and recurrent wheeze in healthy preterm infants. N Engl J Med 2013, 368:1791-1799.
24. Hasegawa K, Jartti T, Mansbach JM, et al. Respiratory syncytial virus genomic load and disease severity among children hospitalized with bronchiolitis: multicenter cohort studies in the United States and Finland. J Infect Dis 2015, 211:1550-1559.
25. Tripp RA, Moore D, Barskey At, et al. Peripheral blood mononuclear cells from infants hospitalized because of respiratory syncytial virus infection express T helper-1 and T helper-2 cytokines and CC chemokine messenger RNA. J Infect Dis 2002, 185:1388-1394.
26. Scagnolari C, Midulla F, Selvaggi C, et al. Evaluation of viral load in infants hospitalized with bronchiolitis caused by respiratory syncytial virus. Med Microbiol Immunol 2012, 201:311-317.
27. Dahl R, Bjermer L Nordic consensus report on asthma management. Nordic Asthma Consensus Group. Respir Med 2000, 94:299-327.